SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-18-000424
Filing Date
2018-02-14
Accepted
2018-02-14 17:23:54
Documents
56
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q sonoma_10q-123117.htm 10-Q 441906
2 CERTIFICATION sonoma_ex3101.htm EX-31.1 8350
3 CERTIFICATION sonoma_ex3102.htm EX-31.2 8298
4 CERTIFICATION sonoma_ex3201.htm EX-32.1 4169
  Complete submission text file 0001683168-18-000424.txt   2998198

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE snoa-20171231.xml EX-101.INS 605222
6 XBRL SCHEMA FILE snoa-20171231.xsd EX-101.SCH 27861
7 XBRL CALCULATION FILE snoa-20171231_cal.xml EX-101.CAL 54674
8 XBRL DEFINITION FILE snoa-20171231_def.xml EX-101.DEF 79600
9 XBRL LABEL FILE snoa-20171231_lab.xml EX-101.LAB 246518
10 XBRL PRESENTATION FILE snoa-20171231_pre.xml EX-101.PRE 195039
Mailing Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954
Business Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954 707-283-0550
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-33216 | Film No.: 18613849
SIC: 2834 Pharmaceutical Preparations